Tagvilda 50mg Tablet
Marketer
Goldline Pharmaceuticals Ltd
Salt Composition
Vildagliptin (50mg)
Overview Tagvilda 50mg Tablet
Glycemia-50 (50mg tablets) is indicated for managing type 2 diabetes. Optimal blood glucose control is achieved through its use in conjunction with a balanced diet and regular physical activity, mitigating risks of serious diabetic complications such as renal impairment and vision loss. Glycemia-50 is typically prescribed when dietary and exercise regimens, or other medications, prove insufficient for blood sugar regulation. It may be administered alone or alongside other antidiabetic agents. Dosage is determined by individual health status and blood glucose readings, and should be taken as directed by your physician, with or without food. Consistent daily dosing at the same time maximizes therapeutic efficacy. Discontinuation should only occur under medical supervision. Adherence to the recommended diet and exercise plan is crucial for effective diabetes management. Your lifestyle significantly impacts diabetic control. Common adverse effects include hypoglycemia, tremors, headache, vertigo, weariness, and nausea. Recognizing hypoglycemic symptoms (e.g., lightheadedness, perspiration, dizziness, syncope, dry mouth) and having readily available glucose sources (like candy) is essential. Persistent or concerning side effects warrant immediate medical attention. Prior to commencing treatment, inform your physician of any history of kidney or heart disease, or pancreatic disorders. Pregnant or lactating individuals should seek medical counsel before initiating therapy. Potential drug interactions necessitate disclosure of all concurrent medications. Alcohol consumption should be minimized due to an elevated risk of hypoglycemia. Regular monitoring, including kidney function and blood glucose levels, is necessary to assess treatment efficacy.
Primary Ingredients of Tagvilda 50mg Tablet
No text provided to rephrase.
Uses of Tagvilda 50mg Tablet
Managing Type 2 diabetes
Major Benefits of Tagvilda 50mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the 50mg Tagvilda tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken on an empty stomach; however, consistent daily timing is recommended.
Common Side effects of Tagvilda 50mg Tablet:
- Hypoglycemia (low blood glucose level)
- Tremors
- Headache
- Dizziness
- Fatigue
- Nausea
How to use Tagvilda 50mg Tablet:
Administer Tagvilda 50mg Tablet as prescribed by your physician, ingesting the medication whole. Avoid chewing, crushing, or fracturing the tablet. This medication can be taken with or without food; however, consistent daily timing is recommended.
How Tagvilda 50mg Tablet works:
Tagvilda 50mg tablets are used to manage diabetes. Their mechanism involves stimulating insulin secretion from the pancreas and suppressing hormones that elevate blood glucose. Consequently, both fasting and postprandial blood sugar are lowered.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Tagvilda 50mg Tablet may pose unknown risks; physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Using Tagvilda 50mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against potential dangers prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Tagvilda 50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a 50mg Tagvilda tablet might cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
For individuals with kidney impairment, Tagvilda 50mg tablets are generally considered safe. A dosage alteration for Tagvilda 50mg is typically unnecessary. Nevertheless, patients experiencing moderate to severe kidney disease may need a modified dosage. Physician consultation is advised.
LiverUNSAFE
Use of Tagvilda 50mg tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Seek medical counsel.
What if you forget to take Tagvilda 50mg Tablet :
Should you forget a Tagvilda 50mg Tablet dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tagvilda 50mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Pyrrolidinecarbonitrile derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Dipeptidyl peptidase-4 inhibitors |
3,018 People bought this recently